Calif. Federal Judge Dismisses Lilly’s Suit Against Mochi For Compounded Drug

SAN FRANCISCO — A California federal judge found that Eli Lilly and Co. failed to show that it was injured by a telehealth company selling a compounded version of tirzepatide, a...

Already a subscriber? Click here to view full article